clarithromycin

1 January, 2020

Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study

2023-02-16T14:31:00+03:00By hiss|Categories: Publications, Therapeutics|Tags: azithromycin, clarithromycin, pneumonia|

Evdoxia Kyriazopoulou, Dimitrios Sinapidis, Stamatios Halvatzis, Dimitrios Velissaris, Nikolaos Alexiou, Vasilios Kosmas, Maria-Evangelia Adami, Miltiades Kyprianou, Aikaterini Kyprianou, Aggelos Stefos, Malvina Lada, Pantelis Koutoukas, Maria Pavlaki, Anna Kyriakoudi, Anna Makina, Charalambos Gogos, Michael S Niederman, Evangelos J. Giamarellos-Bourboulis International Journal of Antimicrobial Agents 2020 Jan;55(1):105836 DOI: 10.1016/j.ijantimicag.2019.10.017View article 🡇 Funding The works were

INCLASS

2023-01-09T12:15:00+03:00By hiss|Categories: Completed, Interventional, Sepsis and severe infections, Studies|Tags: clarithromycin, Sepsis|

Completed study Official Study Title A double-blind, randomized, placebo-controlled clinical study of the efficacy of INtravenous CLArithromycin as adjunctive treatment in patients with Sepsis and respiratory and multiple organ dysfunction Syndrome Brief Description INCLASS is a randomized clinical trial aiming to compare the efficacy of intravenous clarithromycin over placebo in patients with sepsis and

Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis

2023-02-16T15:31:14+03:00By hiss|Categories: Other Grants, Publications|Tags: clarithromycin, Sepsis|

Thomas Tsaganos, Maria Raftogiannis, Maria Pratikaki, Sofia Christodoulou, Anastasia Kotanidou, Evangelos Papadomichelakis, Apostolos Armaganidis, Christina Routsi, Evangelos J. Giamarellos-Bourboulis Antimicrobial Agents and Chemotherapy 2016 May 23;60(6):3640-6 DOI: 10.1128/AAC.02974-15View article 🡇 Funding The study was funded by the Hellenic Institute for the Study of Sepsis. Keywords: pneumonia; sepsis